体育精神病学家对运动员患者在竞技水平上的精神治疗偏好:2024年更新。

IF 1.9 4区 医学 Q2 ORTHOPEDICS
Claudia L Reardon, Malte Christian Claussen, Shane Creado, Alan Currie, Carla D Edwards
{"title":"体育精神病学家对运动员患者在竞技水平上的精神治疗偏好:2024年更新。","authors":"Claudia L Reardon, Malte Christian Claussen, Shane Creado, Alan Currie, Carla D Edwards","doi":"10.1080/00913847.2025.2495545","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Only two small, prior studies ascertained psychiatric treatment preferences for athletes among sports psychiatrists. This study aims to build upon and update those results by describing comprehensive psychiatric treatment preferences and rationales for those preferences, across competitive levels of athletes, among practicing sports psychiatrists.</p><p><strong>Methods: </strong>In 2024, organizations with large concentrations of sports psychiatrists were provided an invitation regarding an anonymous, web-based survey on psychiatric treatment preferences in working with athletes with mental health symptoms and disorders.</p><p><strong>Results: </strong>Seventy-five respondents who identified as psychiatrists or psychiatrists in training and who had treated athlete-patients within the past 3 years completed the survey. Top choices of psychiatric medications for athletes included bupropion for depression without anxiety; escitalopram for depression with anxiety, generalized anxiety disorder, and social anxiety disorder; sertraline for obsessive-compulsive disorder, panic disorder, and post-traumatic stress disorder; melatonin for insomnia; methylphenidate extended release osmotic-controlled release oral delivery system for attention-deficit/hyperactivity disorder; aripiprazole for bipolar spectrum disorder (manic/hypomanic phase); lamotrigine for bipolar spectrum disorder (depressive and maintenance/prophylaxis phases); and aripiprazole for psychotic disorders. Regarding side effects, respondents reported being most concerned about sedation/somnolence, weight gain, and reduction in performance. The majority of respondents indicated they order a variety of medical evaluations at least as often or more often with athletes compared to non-athletes. The first choice of psychotherapy <i>setting</i> was individual psychotherapy, followed by family therapy, and then a tie between couples therapy and group therapy. The preferred <i>type</i> of psychotherapy was cognitive behavioral therapy followed by a tie among behavioral therapy, dialectical behavioral therapy, and mindfulness.</p><p><strong>Conclusion: </strong>Sports psychiatrists tend to prefer medications that are relatively more energizing and less likely to cause weight gain. They undertake medical evaluations for their athlete-patients with relatively great frequency. Their preferred psychotherapy types are skills-based and can be completed within relatively short time-frames.</p>","PeriodicalId":51268,"journal":{"name":"Physician and Sportsmedicine","volume":" ","pages":"1-11"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Psychiatric treatment preferences of sports psychiatrists for athlete-patients across competitive levels: a 2024 update.\",\"authors\":\"Claudia L Reardon, Malte Christian Claussen, Shane Creado, Alan Currie, Carla D Edwards\",\"doi\":\"10.1080/00913847.2025.2495545\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Only two small, prior studies ascertained psychiatric treatment preferences for athletes among sports psychiatrists. This study aims to build upon and update those results by describing comprehensive psychiatric treatment preferences and rationales for those preferences, across competitive levels of athletes, among practicing sports psychiatrists.</p><p><strong>Methods: </strong>In 2024, organizations with large concentrations of sports psychiatrists were provided an invitation regarding an anonymous, web-based survey on psychiatric treatment preferences in working with athletes with mental health symptoms and disorders.</p><p><strong>Results: </strong>Seventy-five respondents who identified as psychiatrists or psychiatrists in training and who had treated athlete-patients within the past 3 years completed the survey. Top choices of psychiatric medications for athletes included bupropion for depression without anxiety; escitalopram for depression with anxiety, generalized anxiety disorder, and social anxiety disorder; sertraline for obsessive-compulsive disorder, panic disorder, and post-traumatic stress disorder; melatonin for insomnia; methylphenidate extended release osmotic-controlled release oral delivery system for attention-deficit/hyperactivity disorder; aripiprazole for bipolar spectrum disorder (manic/hypomanic phase); lamotrigine for bipolar spectrum disorder (depressive and maintenance/prophylaxis phases); and aripiprazole for psychotic disorders. Regarding side effects, respondents reported being most concerned about sedation/somnolence, weight gain, and reduction in performance. The majority of respondents indicated they order a variety of medical evaluations at least as often or more often with athletes compared to non-athletes. The first choice of psychotherapy <i>setting</i> was individual psychotherapy, followed by family therapy, and then a tie between couples therapy and group therapy. The preferred <i>type</i> of psychotherapy was cognitive behavioral therapy followed by a tie among behavioral therapy, dialectical behavioral therapy, and mindfulness.</p><p><strong>Conclusion: </strong>Sports psychiatrists tend to prefer medications that are relatively more energizing and less likely to cause weight gain. They undertake medical evaluations for their athlete-patients with relatively great frequency. Their preferred psychotherapy types are skills-based and can be completed within relatively short time-frames.</p>\",\"PeriodicalId\":51268,\"journal\":{\"name\":\"Physician and Sportsmedicine\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physician and Sportsmedicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/00913847.2025.2495545\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physician and Sportsmedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00913847.2025.2495545","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

摘要

目的:只有两个小的,先前的研究确定了运动员在运动精神病学家中的精神治疗偏好。这项研究的目的是建立和更新这些结果,通过描述全面的精神病学治疗偏好和这些偏好的基本原理,跨越运动员的竞技水平,在执业运动精神病学家中。方法:在2024年,向拥有大量体育精神科医生的组织发出邀请,就有精神健康症状和障碍的运动员的精神治疗偏好进行匿名的网络调查。结果:75名被调查的精神科医生或训练中的精神科医生在过去3年内治疗过运动员病人。运动员首选的精神科药物包括安非他酮治疗无焦虑抑郁;艾司西酞普兰治疗抑郁伴焦虑、广泛性焦虑障碍和社交焦虑障碍;舍曲林治疗强迫症、恐慌症和创伤后应激障碍;褪黑素治疗失眠;哌甲酯缓释渗透控释口服给药系统治疗注意缺陷/多动障碍阿立哌唑治疗双相情感障碍(躁狂/轻躁期);拉莫三嗪治疗双相情感障碍(抑郁期和维持/预防期);阿立哌唑治疗精神障碍。关于副作用,受访者报告最担心的是镇静/嗜睡、体重增加和表现下降。大多数答复者表示,与非运动员相比,他们对运动员进行各种医疗评估的频率至少相同,甚至更多。心理治疗设置的首选是个人心理治疗,其次是家庭治疗,然后是夫妻治疗和团体治疗。首选的心理治疗类型是认知行为疗法,其次是行为疗法、辩证行为疗法和正念疗法。结论:运动精神科医生倾向于选择那些相对更有活力、不太可能导致体重增加的药物。他们对运动员病人进行医疗评估的频率相对较高。他们喜欢的心理治疗类型是基于技能的,可以在相对较短的时间内完成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Psychiatric treatment preferences of sports psychiatrists for athlete-patients across competitive levels: a 2024 update.

Objectives: Only two small, prior studies ascertained psychiatric treatment preferences for athletes among sports psychiatrists. This study aims to build upon and update those results by describing comprehensive psychiatric treatment preferences and rationales for those preferences, across competitive levels of athletes, among practicing sports psychiatrists.

Methods: In 2024, organizations with large concentrations of sports psychiatrists were provided an invitation regarding an anonymous, web-based survey on psychiatric treatment preferences in working with athletes with mental health symptoms and disorders.

Results: Seventy-five respondents who identified as psychiatrists or psychiatrists in training and who had treated athlete-patients within the past 3 years completed the survey. Top choices of psychiatric medications for athletes included bupropion for depression without anxiety; escitalopram for depression with anxiety, generalized anxiety disorder, and social anxiety disorder; sertraline for obsessive-compulsive disorder, panic disorder, and post-traumatic stress disorder; melatonin for insomnia; methylphenidate extended release osmotic-controlled release oral delivery system for attention-deficit/hyperactivity disorder; aripiprazole for bipolar spectrum disorder (manic/hypomanic phase); lamotrigine for bipolar spectrum disorder (depressive and maintenance/prophylaxis phases); and aripiprazole for psychotic disorders. Regarding side effects, respondents reported being most concerned about sedation/somnolence, weight gain, and reduction in performance. The majority of respondents indicated they order a variety of medical evaluations at least as often or more often with athletes compared to non-athletes. The first choice of psychotherapy setting was individual psychotherapy, followed by family therapy, and then a tie between couples therapy and group therapy. The preferred type of psychotherapy was cognitive behavioral therapy followed by a tie among behavioral therapy, dialectical behavioral therapy, and mindfulness.

Conclusion: Sports psychiatrists tend to prefer medications that are relatively more energizing and less likely to cause weight gain. They undertake medical evaluations for their athlete-patients with relatively great frequency. Their preferred psychotherapy types are skills-based and can be completed within relatively short time-frames.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Physician and Sportsmedicine
Physician and Sportsmedicine PRIMARY HEALTH CARE-ORTHOPEDICS
CiteScore
4.90
自引率
4.30%
发文量
60
审稿时长
>12 weeks
期刊介绍: The Physician and Sportsmedicine is a peer-reviewed, clinically oriented publication for primary care physicians. We examine the latest drug discoveries to advance treatment and recovery, and take into account the medical aspects of exercise therapy for a given condition. We cover the latest primary care-focused treatments serving the needs of our active patient population, and assess the limits these treatments govern in stabilization and recovery. The Physician and Sportsmedicine is a peer-to-peer method of communicating the latest research to aid primary care physicians’ advancement in methods of care and treatment. We routinely cover such topics as: managing chronic disease, surgical techniques in preventing and managing injuries, the latest advancements in treatments for helping patients lose weight, and related exercise and nutrition topics that can impact the patient during recovery and modification.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信